# Safety and Efficacy Study of RENEWAL 4 AVT

> **NCT00180336** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 170 (—)

## Conditions studied

- Heart Failure
- Tachycardia
- Atrial Fibrillation
- Atrial Flutter
- Ventricular Fibrillation

## Interventions

- **DEVICE:** CRT-D

## Key facts

- **NCT ID:** NCT00180336
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 170 (—)
- **Last updated:** 2007-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180336, "Safety and Efficacy Study of RENEWAL 4 AVT". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00180336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*